S. Farkona
Oncology · 2016
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 44 citations into it
- Immunology — 37 citations into it
Whom S. Farkona trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Padmanee Sharma
- S. Rosenberg
- James P. Allison
- I. Mellman
- Daniel S. Chen
- I. Melero
- Antoni Ribas
- Jie Yang
- J. Wolchok
- D. Hanahan
Who trusts S. Farkona overall
Papers from S. Farkona's perspective
Ordered by how strongly the researchers S. Farkona trusts endorse each paper. Same corpus, a different order for every researcher.
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised,… (The Lancet Oncology)
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (New England Journal of Medicine)
- CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms (Molecular and Cellular Biology)
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (Journal of Experimental Medicine)
- Novel cancer immunotherapy agents with survival benefit: recent successes and next steps (Nature Reviews. Cancer)
- SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 (Journal of Immunology)
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (Science)
- Hallmarks of cancer: the next generation. (Cell)
Their papers
- Cancer immunotherapy: the beginning of the end of cancer? (2016) — 1,070 citations